PRESS RELEASE
News
-
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
-
Worksport (Nasdaq: WKSP) Books $2.92M August Orders; Annualized Order Run Rate Reaches $35M
-
Golden Minerals Commences Drilling at its Desierto Property, Argentina
-
INEO to Present at LD Micro 20th Annual Main Event on October 21, 2026
-
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
-
Precisely Launches AI Studio to Jumpstart Enterprise AI Development
-
Precisely Introduces New Unified Data Management Platform to Make Enterprise Data AI-Ready
-
Optro Establishes UAE Hub to Support Rapid Transition to Agentic GRC Across the Middle East
-
Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
-
Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
-
AXA - Elimination of the dilutive impact of Shareplan 2026
-
AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
-
Disclosure of shares outstanding and voting rights - 05.10.2026
-
Déclaration nombre d'actions et droits de vote - 05.10.2026
-
LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026